UK shareholder meetings calendar - next 7 days
22nd Jan 2026 17:13
| Price | 11.00p on 06-02-2026 at 08:00:38 |
|---|---|
| Change | -0.90p -7.56% |
| Buy | 12.00p |
| Sell | 10.00p |
| Last Trade: | Buy 8,965.00 at 11.10888p |
| Day's Volume: | 3,000 |
| Last Close: | 11.90p |
| Open: | 11.90p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 11.00p - 11.90p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £675.56m |
| VWAP: | 11.90p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 8,965 | 11.10888p | Ordinary |
14:57:56 - 05-Feb-26 |
| Sell* | 405 | 10.50p | Ordinary |
14:46:57 - 05-Feb-26 |
| Buy* | 110 | 11.10888p | Ordinary |
14:11:42 - 05-Feb-26 |
| Buy* | 1 | 11.10888p | Ordinary |
12:33:18 - 05-Feb-26 |
| Sell* | 76 | 10.565p | Ordinary |
09:02:30 - 05-Feb-26 |
| Buy* | 180 | 11.10888p | Ordinary |
08:47:15 - 05-Feb-26 |
| Buy* | 2,000 | 11.90p | Suspected BUY Trade |
16:35:11 - 04-Feb-26 |
| Buy* | 45,000 | 11.1477p | Ordinary |
15:10:32 - 04-Feb-26 |
| Sell* | 5,148 | 10.565p | Ordinary |
13:33:36 - 04-Feb-26 |
| Sell* | 10,000 | 10.555p | Ordinary |
12:16:21 - 04-Feb-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |
| 29th Jan 2026 2:13 pm | RNS | Result of Annual General Meeting |
| 28th Jan 2026 4:48 pm | RNS | Grant of Options under Long Term Incentive Scheme |
| 19th Jan 2026 7:00 am | RNS | Half Year Trading Update |
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |